TRANSVAC: new vaccines faster

Welcome to TRANSVAC, a collaborative infrastructure project funded under the European Commission’s (EC) 7th Framework Programme (FP7). The project is the joint effort of leading European groups in the field of vaccine development, and is coordinated by the European Vaccine Initiative (EVI). TRANSVAC was designed in order to enhance European research and training and foster the seamless implementation of a permanent research infrastructure for early vaccine development in Europe.

In order to reach its ambitious goal, TRANSVAC carries out activities at various levels. On this website you can find out about how to benefit from TRANSVAC’s portfolio of activities, learn how to apply for access to the TRANSVAC’s high-quality Infrastructure Free Services and Paid Services, how to participate in the free Workshops on Animal Models or in the free Modular Course on Concepts on Vaccine Development. Finally, TRANSVAC looks to the future and is exploring the implementation of a road map towards a sustainable European vaccine development platform beyond TRANSVAC. This is done by the European Vaccine Development Stakeholder Working Groups.

News

25 April 2013

World Malaria Day

Clinical Trial Start of a Promising New Malaria Vaccine Candidate

11 April 2013

Third TRANSVAC workshop on animal models - Register for free before 03 May 2013

The third TRANSVAC workshop entitled "The asterix, who cares? Data analysis of animal studies with multi-variables and small number of animals" will take place on 06 June 2013 in Amsterdam, The Netherlands.
The attendance to the workshop is free of charge. Registration deadline: 03 May 2013

10 April 2013

Vacancy for Principal Scientist at Medicines and Healthcare Products Regulatory Agency (MHRA)

The vacancy is at MHRA's Bacteriology Division NIBSC

Deadline 24 April 2013